Metabolic syndrome and benign prostatic hyperplasia: An update.

about

Current consensus and controversies on male LUTS/BPH (part one).

P2860

Q55085373-2E850472-C793-45C5-8026-97EFFD2C0A2D

P2860

Metabolic syndrome and benign prostatic hyperplasia: An update.

Item

http://www.wikidata.org/entity/Q55345009

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Metabolic syndrome and benign prostatic hyperplasia: An update.

@en

Metabolic syndrome and benign prostatic hyperplasia: An update.

@nl

type

Item

label

Metabolic syndrome and benign prostatic hyperplasia: An update.

@en

Metabolic syndrome and benign prostatic hyperplasia: An update.

@nl

prefLabel

Metabolic syndrome and benign prostatic hyperplasia: An update.

@en

Metabolic syndrome and benign prostatic hyperplasia: An update.

@nl

P1476

Metabolic syndrome and benign prostatic hyperplasia: An update.

@en

P2093

Cheung-Hing Cheng

http://www.w3.org/2001/XMLSchema#string

Chi-Man Ng

http://www.w3.org/2001/XMLSchema#string

Ho-Yin Ngai

http://www.w3.org/2001/XMLSchema#string

Kar-Kei Steffi Yuen

http://www.w3.org/2001/XMLSchema#string

Sau-Kwan Peggy Chu

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular and molecular mechanisms of metformin: an overview

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

The metabolic syndrome--a new worldwide definition

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Are statin medications associated with lower urinary tract symptoms in men and women? Results from the Boston Area Community Health (BACH) Survey.

Chronic ischemia alters prostate structure and reactivity in rabbits.

Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms.

Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.

Role of estrogens in human benign prostatic hyperplasia.

P304

164-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.AJUR.2017.05.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29264226

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

5717972

http://www.w3.org/2001/XMLSchema#string

Metabolic syndrome and benign prostatic hyperplasia: An update.

about

P2860

P2860

Metabolic syndrome and benign prostatic hyperplasia: An update.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932